Cite
APA Citation
Kim, S., Pawar, A., Desai, R., Gale, S., Klearman, M., Sarsour, K., Solomon, D., & Schneeweiss, S. (n.d.). oP0002 No difference in the risk of malignancy in tocilizumab versus tnf inhibitor initiators in patients with rheumatoid arthritis: a multi-database cohort study. Annals of the rheumatic diseases, 77, 50. http://access.bl.uk/ark:/81055/vdc_100144730512.0x000053